Literature DB >> 1987043

Role of bacterial association with Kupffer cells in occurrence of endogenous systemic bacteremia.

Y Hirakata1, K Tomono, K Tateda, T Matsumoto, N Furuya, K Shimoguchi, M Kaku, K Yamaguchi.   

Abstract

Bacteremia in immunocompromised hosts often arises from their endogenous intestinal flora. We produced experimental endogenous bacteremia by administering cyclophosphamide and ampicillin to conventional and specific-pathogen-free mice. The frequencies of bacteremia and mortality in the conventional mice were significantly higher than for the specific-pathogen-free mice. Pseudomonas aeruginosa was the major pathogen causing systemic bacteremia in conventional mice and was associated with a high mortality rate. Morganella morganii caused systemic bacteremia in both conventional and specific-pathogen-free mice. In contrast, Escherichia coli, enterococci, or other species most often caused portal bacteremia only. To determine the mechanism of occurrence of systemic bacteremia, we investigated bacterial blood clearance in mice and association with murine Kupffer cells, using several bacterial strains isolated from mice with bacteremia. Blood clearance rates and the abilities of isolated Kupffer cells to associate with bacteria were significantly greater for the organisms causing portal bacteremia than for those causing systemic bacteremia. There were no significant differences between the blood clearance rates in carrageenan-treated mice and that in normal mice. Moreover, association at 4 degrees C was not different from that at 37 degrees C. The results suggest that blood clearance of bacteria reflects bacterial adherence to Kupffer cells and that the resistance of bacteria to association with Kupffer cells plays an important role in the occurrence of overwhelming systemic bacteremia in this animal model.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1987043      PMCID: PMC257739          DOI: 10.1128/iai.59.1.289-294.1991

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  33 in total

1.  Portal bacteraemia in ulcerative colitis.

Authors:  B N BROOKE; G SLANEY
Journal:  Lancet       Date:  1958-06-07       Impact factor: 79.321

2.  Diffusion-in-gel methods for immunological analysis. II.

Authors:  O OUCHTERLONY
Journal:  Prog Allergy       Date:  1962

3.  Epidemiological studies of Pseudomonas species in patients with leukemia.

Authors:  G P Bodey
Journal:  Am J Med Sci       Date:  1970-08       Impact factor: 2.378

4.  Origin of infection in acute nonlymphocytic leukemia. Significance of hospital acquisition of potential pathogens.

Authors:  S C Schimpff; V M Young; W H Greene; G D Vermeulen; M R Moody; P H Wiernik
Journal:  Ann Intern Med       Date:  1972-11       Impact factor: 25.391

5.  Antibiotic treatment and intestinal colonization by Pseudomonas aeruginosa in cancer patients.

Authors:  A Andremont; B Marang; C Tancrède; D Baume; C Hill
Journal:  Antimicrob Agents Chemother       Date:  1989-08       Impact factor: 5.191

6.  Pseudomonas aeruginosa vasculitis and bacteremia following conjunctivitis: a simple model of fatal pseudomonas infection in neutropenia.

Authors:  E J Ziegler; H Douglas
Journal:  J Infect Dis       Date:  1979-03       Impact factor: 5.226

7.  Increased phagocytosis and killing of Escherichia coli treated with subinhibitory concentrations of cefamandole and gentamicin in isolated rat livers.

Authors:  A Andreana; P Perna; R Utili; M Dilillo; G Ruggiero
Journal:  Antimicrob Agents Chemother       Date:  1984-02       Impact factor: 5.191

8.  Hepatic clearance of Salmonella typhimurium in silica-treated mice.

Authors:  R L Friedman; R J Moon
Journal:  Infect Immun       Date:  1977-06       Impact factor: 3.441

9.  Hospital-acquired bloodstream infections with Staphylococcus epidermidis. Review of 100 cases.

Authors:  S Ponce de Leon; R P Wenzel
Journal:  Am J Med       Date:  1984-10       Impact factor: 4.965

10.  Gram-negative pathogens in septicaemic infections.

Authors:  L S Young; P Stevens; B Kaijser
Journal:  Scand J Infect Dis Suppl       Date:  1982
View more
  15 in total

1.  Efficacy of erythromycin lactobionate for treating Pseudomonas aeruginosa bacteremia in mice.

Authors:  Y Hirakata; M Kaku; K Tomono; K Tateda; N Furuya; T Matsumoto; R Araki; K Yamaguchi
Journal:  Antimicrob Agents Chemother       Date:  1992-06       Impact factor: 5.191

2.  Neisseria meningitidis and Escherichia coli are protected from leukocyte phagocytosis by binding to erythrocyte complement receptor 1 in human blood.

Authors:  Ole-Lars Brekke; Bernt Christian Hellerud; Dorte Christiansen; Hilde Fure; Albert Castellheim; Erik Waage Nielsen; Anne Pharo; Julie Katrine Lindstad; Grethe Bergseth; Graham Leslie; John D Lambris; Petter Brandtzaeg; Tom Eirik Mollnes
Journal:  Mol Immunol       Date:  2011-08-11       Impact factor: 4.407

3.  Efficacy of bacteriophage therapy against gut-derived sepsis caused by Pseudomonas aeruginosa in mice.

Authors:  Ryohei Watanabe; Tetsuya Matsumoto; Go Sano; Yoshikazu Ishii; Kazuhiro Tateda; Yoshinobu Sumiyama; Jumpei Uchiyama; Shingo Sakurai; Shigenobu Matsuzaki; Shosuke Imai; Keizo Yamaguchi
Journal:  Antimicrob Agents Chemother       Date:  2006-11-20       Impact factor: 5.191

4.  Adherence to and penetration of human intestinal Caco-2 epithelial cell monolayers by Pseudomonas aeruginosa.

Authors:  Y Hirakata; K Izumikawa; T Yamaguchi; S Igimi; N Furuya; S Maesaki; K Tomono; Y Yamada; S Kohno; K Yamaguchi; S Kamihira
Journal:  Infect Immun       Date:  1998-04       Impact factor: 3.441

5.  Protective Role of Kupffer Cells and Macrophages in Klebsiella pneumoniae-Induced Liver Abscess Disease.

Authors:  Chu Han Hoh; Yi Han Tan; Yunn-Hwen Gan
Journal:  Infect Immun       Date:  2019-08-21       Impact factor: 3.441

Review 6.  Bloodstream infections in patients with liver cirrhosis.

Authors:  Michele Bartoletti; Maddalena Giannella; Russell Edward Lewis; Pierluigi Viale
Journal:  Virulence       Date:  2016-02-11       Impact factor: 5.882

7.  Immunomodulating effect of fosfomycin on gut-derived sepsis caused by Pseudomonas aeruginosa in mice.

Authors:  T Matsumoto; K Tateda; S Miyazaki; N Furuya; A Ohno; Y Ishii; Y Hirakata; K Yamaguchi
Journal:  Antimicrob Agents Chemother       Date:  1997-02       Impact factor: 5.191

8.  Effect of interleukin-10 on gut-derived sepsis caused by Pseudomonas aeruginosa in mice.

Authors:  T Matsumoto; K Tateda; S Miyazaki; N Furuya; A Ohno; Y Ishii; Y Hirakata; K Yamaguchi
Journal:  Antimicrob Agents Chemother       Date:  1998-11       Impact factor: 5.191

9.  Phagocytosis of Treponema pallidum and reactive oxygen species production by isolated rat Kupffer cells.

Authors:  Antonella Marangoni; Rita Aldini; Massimo Guardigli; Vittorio Sambri; Lorenzo Giacani; Marco Montagnani; Aldo Roda; Roberto Cevenini
Journal:  Med Microbiol Immunol       Date:  2003-04-11       Impact factor: 3.402

10.  Potential effects of erythromycin on host defense systems and virulence of Pseudomonas aeruginosa.

Authors:  Y Hirakata; M Kaku; R Mizukane; K Ishida; N Furuya; T Matsumoto; K Tateda; K Yamaguchi
Journal:  Antimicrob Agents Chemother       Date:  1992-09       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.